According to MarketsandMarkets™, The global CRISPR market is projected to grow from USD 3.21 billion in 2025 to USD 5.47 billion by 2030, at a CAGR of 11.2% during the forecast period. The market is witnessing significant growth due to the increasing demand for gene and cell therapies, rising investments in genomic research, and expanding applications of CRISPR technology across drug discovery, agriculture, and diagnostics.
Browse 301 market data Tables and 50 Figures spread through 266 Pages and in-depth TOC on “CRISPR Market “.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134401204
Advancements in CRISPR-based tools, improved delivery systems, and a growing number of clinical trials focused on gene editing therapies are further accelerating market adoption. Additionally, strategic collaborations between biotechnology companies and academic institutions, along with supportive government policies, are enhancing access to CRISPR technologies across both developed and emerging markets.
Services Segment to Register Strong Growth
By offering, the services segment is expected to grow at a significant CAGR during the forecast period. This segment includes gRNA synthesis, cell line development, screening, validation, and other specialized services.
The increasing demand for customized and high-throughput gene editing solutions among pharmaceutical companies, biotechnology firms, and research institutions is a major driver of this segment. The expanding use of CRISPR in therapeutics and diagnostics further supports the need for scalable and comprehensive service offerings.
CRISPR Kits & Enzymes Lead Product Segment
Within the products category, the CRISPR kits & enzymes segment accounted for the largest share in 2024 and is expected to maintain strong growth. These products are essential components in gene editing workflows, including genome modification, gene knockout, and validation studies.
Their widespread use across academic research, biotechnology, and pharmaceutical industries—often in large volumes—continues to drive demand for high-quality and reliable CRISPR reagents.
Pharmaceutical & Biotechnology Companies to Drive Demand
By end user, pharmaceutical and biotechnology companies are projected to register the highest growth rate during the forecast period. These organizations are heavily investing in drug discovery, gene therapy, and precision medicine initiatives.
CRISPR-based services such as cell line engineering, high-throughput screening, and gRNA synthesis play a critical role in accelerating research and development processes, enabling faster innovation in therapeutic development.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=134401204
Asia Pacific Emerges as High-Growth Region
While North America currently holds the largest share of the CRISPR market, the Asia Pacific region is expected to witness significant growth during the forecast period. This growth is driven by increasing healthcare demand, expanding biotechnology research capabilities, and rising investments in life sciences.
Countries such as China, India, and Japan are making substantial advancements in biotechnology and drug discovery, further boosting the adoption of CRISPR technologies in the region.
Competitive Landscape
Key players in the CRISPR market include Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), and GenScript (US), among others.
These companies are focusing on innovation, strategic partnerships, and expanding their product and service portfolios to strengthen their position in the competitive landscape.
Related Reports:
Gene Editing Market – Global Forecast to 2029
Genomics Market – Global Forecast to 2030
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Rohan SalgarkarEmail: Send EmailPhone: 18886006441Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445City: FloridaState: FloridaCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/crispr-technology-market-134401204.html
